Sana Biotechnology Announces Preclinical Data Published in Nature Communications
Hypoimmune-modified allogeneic CD19-directed CAR T cells can evade immune detection and kill tumor cells in a novel humanized allogeneic...
Sana Biotechnology Announces Preclinical Data Published in Nature Communications
Ring Therapeutics Raises $86.5M in Series C Funding to Create Next Generation Programmable Medicines
Aera Therapeutics Launches with $193 M for the Next Generation of Transformative Genetic Medicines
Tessera Therapeutics Highlights Advancements Across its Gene Writing™ and Delivery Platforms
eFFECTOR Therapeutics Provides Positive Clinical Data Update for Zotatifin
DNA Writing Goes Enzymatic, Encourages Pursuit of Bold Visions
Nuvation Bio Doses First Patient in Phase 1b Combination Study of NUV-868
Federation Bio Administers First Dose in Phase 1 Clinical Trial
Escient Pharmaceuticals Announces $120 Million Series C Financing